Mark Boldin
- Cancer Research top 0.05%
- MicroRNA in disease regulation 28
- Cancer-related molecular mechanisms research 12
- NF-κB Signaling Pathways 10
- Immunology top 0.2%
- Immune Response and Inflammation 8
- interferon and immune responses 7
- Immune Cell Function and Interaction 7
- Molecular Biology top 0.2%
- Circular RNAs in diseases 11
- Cell death mechanisms and regulation 8
- Oncology top 1%
- Neurology top 2%
- Co-authors
- David BaltimoreKonstantin D. TaganovDavid WallachRyan M. O’ConnellTanya GoncharovNikolay MalininEugene VarfolomeevDinesh S. Rao
- Journals
- Proceedings of the National Academy of Sciences (6 papers)Blood (5 papers)The Journal of Experimental Medicine (4 papers)
- Partner nations
- United StatesIsraelEstonia
In The Last Decade
Mark Boldin
52 papers receiving 16.3k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Cancer Research 8.7k
- Immunology 6.3k
- Molecular Biology 10.5k
- Oncology 1.8k
- Neurology 356
Countries citing papers authored by Mark Boldin
This map shows the geographic impact of Mark Boldin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Boldin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Boldin more than expected).
Fields of papers citing papers by Mark Boldin
This network shows the impact of papers produced by Mark Boldin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Boldin. The network helps show where Mark Boldin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Boldin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2022 | 5 | |
| 3 | 2022 | 13 | |
| 4 | 2020 | 41 | |
| 5 | 2020 | 28 | |
| 6 | 2017 | 115 | |
| 7 | 2016 | 145 | |
| 8 | Identification of targets of tumor suppressor microRNA-34a using a reporter library system | 2016 | 2 |
| 9 | 2014 | 161 | |
| 10 | miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in micebreakdown → | 2011 | 704 |
| 11 | Function of miR-146a in Controlling Treg Cell-Mediated Regulation of Th1 Responsesbreakdown → | 2010 | 819 |
| 12 | Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorderbreakdown → | 2008 | 557 |
| 13 | MicroRNAs: new regulators of immune cell development and functionbreakdown → | 2008 | 923 |
| 14 | 2008 | 173 | |
| 15 | MicroRNA-155 is induced during the macrophage inflammatory responsebreakdown → | 2007 | 1552 |
| 16 | 2002 | 40 | |
| 17 | MAP3K-related kinase involved in NF-KB induction by TNF, CD95 and IL-1breakdown → | 1997 | 1153 |
| 18 | Involvement of MACH, a Novel MORT1/FADD-Interacting Protease, in Fas/APO-1- and TNF Receptor–Induced Cell Deathbreakdown → | 1996 | 1991 |
| 19 | 1996 | 109 | |
| 20 | A Novel Protein That Interacts with the Death Domain of Fas/APO1 Contains a Sequence Motif Related to the Death Domainbreakdown → | 1995 | 850 |
About Mark Boldin
Mark Boldin is a scholar working on Cancer Research, Immunology and Developmental Neuroscience, having authored 52 papers that have together received 16.5k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (28 papers), Cancer-related molecular mechanisms research (12 papers), Circular RNAs in diseases (11 papers), NF-κB Signaling Pathways (10 papers), Cell death mechanisms and regulation (8 papers), Immune Response and Inflammation (8 papers), interferon and immune responses (7 papers) and Immune Cell Function and Interaction (7 papers). The work is most often cited by research in Cancer Research (8.7k citations), Immunology (6.3k citations) and Molecular Biology (10.5k citations). Mark Boldin has collaborated with scholars based in United States, Israel and Estonia. Frequent co-authors include David Baltimore, Konstantin D. Taganov, David Wallach, Ryan M. O’Connell, Tanya Goncharov, Nikolay Malinin, Eugene Varfolomeev, Dinesh S. Rao, Genhong Cheng and Igor Mett. Their work appears in journals such as Proceedings of the National Academy of Sciences, Blood, The Journal of Experimental Medicine, The Journal of Cell Biology and Current Opinion in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.